The Briefing

Continuous newsroom coverage of clinically relevant evidence — newest first.

Earlier

24 stories
  1. MIPD Improves Early Postoperative Activity, Reduces Stress for Pancreatic Resection
    JAMA Surgery ·Randomized Controlled Trial · May 21, 2026

    MIPD Improves Early Postoperative Activity, Reduces Stress for Pancreatic Resection

    A randomized trial shows minimally invasive pancreatoduodenectomy leads to higher physical activity and heart rate variability for weeks.

  2. IL-6 Inhibition Shows Clinical Signals in Refractory Depression
    JAMA Psychiatry ·Randomized Controlled Trial · May 21, 2026

    IL-6 Inhibition Shows Clinical Signals in Refractory Depression

    A small trial of tocilizumab for difficult-to-treat depression suggests potential for symptom improvement and identifies patient selection markers.

  3. Diabetes Worsens Bronchiectasis Outcomes, Increases Comorbidities and Infection Risk
    Lancet Respiratory Medicine ·Cohort Study · May 21, 2026

    Diabetes Worsens Bronchiectasis Outcomes, Increases Comorbidities and Infection Risk

    A large registry analysis confirms diabetes significantly impacts disease severity, exacerbations, hospitalizations, and mortality in bronchiectasis.

  4. Buried DIEP Flaps Show Similar Complication Rates to Skin Paddle Flaps
    Plastic & Reconstructive Surgery ·Cohort Study · May 21, 2026

    Buried DIEP Flaps Show Similar Complication Rates to Skin Paddle Flaps

    A retrospective review suggests completely burying deep inferior epigastric perforator flaps does not increase overall complication rates.

  5. Anhedonia Severity Predicts Intermittent Theta-Burst Stimulation Response in MDD
    Biological psychiatry. Cognitive neuroscience and neuroimaging ·Cohort Study · May 21, 2026

    Anhedonia Severity Predicts Intermittent Theta-Burst Stimulation Response in MDD

    Baseline anhedonia levels influence neurophysiological and clinical outcomes following iTBS for major depressive disorder.

  6. Nasal Septal Perforation Impairs Olfactory and Trigeminal Function
    Rhinology ·Cross-Sectional Study · May 21, 2026

    Nasal Septal Perforation Impairs Olfactory and Trigeminal Function

    A cross-sectional study links larger perforation areas and higher BMI to worse olfactory identification in patients with NSP.

  7. Subsolid Lung Nodules Show High 5-Year Survival, Low Nodule-Related Mortality
    CHEST Journal ·Cohort Study · May 21, 2026

    Subsolid Lung Nodules Show High 5-Year Survival, Low Nodule-Related Mortality

    A large cohort study clarifies the natural history and long-term outcomes of subsolid and ground-glass lung nodules.

  8. Weight Loss Intervention Safe in Older AF Patients, But Does Not Improve Symptoms
    JAMA ·Randomized Controlled Trial · May 21, 2026

    Weight Loss Intervention Safe in Older AF Patients, But Does Not Improve Symptoms

    A randomized clinical trial indicates that while weight loss is achievable and safe in older, overweight AF patients, it may not reduce AF symptoms.

  9. Individual LPFC Maps Reveal Fine-Grained, Interdigitated Networks
    Neuron ·Cohort Study · May 21, 2026

    Individual LPFC Maps Reveal Fine-Grained, Interdigitated Networks

    Precision fMRI in 10 individuals shows the lateral prefrontal cortex has a more fragmented and functionally distinct organization than group.

  10. MIF Modulates Astrocyte Distribution in Schizophrenia Cortical Spheroids
    Brain ·In Vitro Study · May 21, 2026

    MIF Modulates Astrocyte Distribution in Schizophrenia Cortical Spheroids

    A new study using patient-derived brain models identifies macrophage migration inhibitory factor (MIF) as a key regulator of astrocyte function.

  11. Azithromycin Does Not Reduce Acute Wheezing Severity in Preschoolers
    New England Journal of Medicine ·Randomized Controlled Trial · May 21, 2026

    Azithromycin Does Not Reduce Acute Wheezing Severity in Preschoolers

    A multicenter trial found azithromycin offered no significant clinical benefit over placebo for moderate-to-severe wheezing symptoms.

  12. Melittin Mitigates Doxorubicin-Induced Neurotoxicity in Murine Models
    Brain Research ·Animal Study · May 21, 2026

    Melittin Mitigates Doxorubicin-Induced Neurotoxicity in Murine Models

    A study in mice suggests melittin, a bee venom component, reduces doxorubicin's neurotoxic effects by targeting inflammation and oxidative stress.

  13. TSPO Deletion Reduces Cortical Spreading Depolarization in Mice
    Brain Research ·Animal Study · May 21, 2026

    TSPO Deletion Reduces Cortical Spreading Depolarization in Mice

    A new study in mice suggests that modulating translocator protein 18 kDa may influence CSD generation and associated neurovascular and inflammatory re

  14. Low-Dose IL-2 Fails to Expand Tregs After Alemtuzumab in RRMS
    PubMed ·In Vitro Study · May 21, 2026

    Low-Dose IL-2 Fails to Expand Tregs After Alemtuzumab in RRMS

    A mechanistic study reveals that low-dose interleukin-2 alone does not boost regulatory T cells in alemtuzumab-treated multiple sclerosis patients.

  15. Vertebrobasilar and Middle Cerebral Aneurysms Carry Highest Case Fatality Rates
    Neurology ·Cohort Study · May 21, 2026

    Vertebrobasilar and Middle Cerebral Aneurysms Carry Highest Case Fatality Rates

    A population-based study of 13,470 cases shows that aneurysm location significantly influences sudden death and 30-day mortality risks.

  16. MSK1 Mediates BDNF Signaling in Striatal Development, Affecting Psychiatric-Relevant Behaviors
    Molecular Psychiatry ·Animal Study · May 20, 2026

    MSK1 Mediates BDNF Signaling in Striatal Development, Affecting Psychiatric-Relevant Behaviors

    A new study identifies mitogen- and stress-activated kinase 1 (MSK1) as a key mediator in brain-derived neurotrophic factor (BDNF) pathways critical.

  17. Inhaled Treprostinil Slows Lung Function Decline, Reduces Clinical Worsening in IPF
    New England Journal of Medicine ·Randomized Controlled Trial · May 20, 2026

    Inhaled Treprostinil Slows Lung Function Decline, Reduces Clinical Worsening in IPF

    A phase 3 trial demonstrates that inhaled treprostinil significantly mitigates FVC reduction and clinical deterioration in patients with idiopathic.

  18. Validating Generative AI Therapeutics: A Proposed Framework for Clinical Integration
    World Psychiatry ·Consensus Statement · May 20, 2026

    Validating Generative AI Therapeutics: A Proposed Framework for Clinical Integration

    A new framework outlines a multi-stage validation process to ensure the safety and efficacy of generative AI agents in mental health care.

  19. Cerebellar iTBS Improves Post-Stroke Cognition via Dentate Nucleus-Ventromedial Thalamus Pathway
    Brain Research ·Animal Study · May 20, 2026

    Cerebellar iTBS Improves Post-Stroke Cognition via Dentate Nucleus-Ventromedial Thalamus Pathway

    A mouse model study identifies the specific neural circuit mediating the cognitive benefits of intermittent theta-burst stimulation after stroke.

  20. Fine Particulate Matter Increases Risk of Recurrent Stroke and Death
    Neurology ·Cohort Study · May 20, 2026

    Fine Particulate Matter Increases Risk of Recurrent Stroke and Death

    A national cohort study finds that PM2.5 exposure nearly triples the risk of stroke recurrence and secondary cardiovascular events.

  21. Cathepsin S Links to Tissue Remodeling, Severity in Chronic Rhinosinusitis with Nasal Polyps
    Rhinology ·Mendelian Randomization Study · May 20, 2026

    Cathepsin S Links to Tissue Remodeling, Severity in Chronic Rhinosinusitis with Nasal Polyps

    Integrative multi-omics analysis identifies cathepsin S (CTSS) as a key mediator of tissue remodeling and disease severity in CRSwNP.

  22. 4% Tetrasodium EDTA Lock Reduces CVAD Complications in ICU Adults
    JAMA ·Randomized Controlled Trial · May 20, 2026

    4% Tetrasodium EDTA Lock Reduces CVAD Complications in ICU Adults

    A multicenter, cluster-randomized trial shows 4% t-EDTA locking fluid decreases a composite of CVAD-associated events, primarily catheter occlusions.

  23. VSED with Hospice: Clinical Course, Symptom Management, and Patient Demographics
    Journal of Pain and Symptom Management ·Case Series · May 20, 2026

    VSED with Hospice: Clinical Course, Symptom Management, and Patient Demographics

    A case series details the clinical trajectory, symptom burden, and care needs of patients choosing voluntarily stopping eating and drinking.

  24. Tezepelumab Reduces Oral Corticosteroid Use in Severe Asthma
    Lancet Respiratory Medicine ·Randomized Controlled Trial · May 20, 2026

    Tezepelumab Reduces Oral Corticosteroid Use in Severe Asthma

    A phase 3 trial demonstrates that tezepelumab significantly lowers daily oral corticosteroid dose in adults with severe, OCS-dependent asthma.